NeuralStem is a clinical-stage biopharmaceutical company. The Company's patented technology enables the commercial-scale production of multiple types of central nervous system stem cells, which are under development for the potential treatment of Ischemic Paraplegia, Traumatic Spinal Cord Injury, ALS and Parkinsona's Disease. NeuralStem's research has allowed them to produce mature, commercial quantities of neural stem cells that can be transplanted into humans as treatments for currently incurable diseases.


Type
Public
HQ
Rockville, US
Founded
1996
Size (employees)
11 (est)
NeuralStem was founded in 1996 and is headquartered in Rockville, US
Report incorrect company information

NeuralStem Office Locations

NeuralStem has an office in Rockville
Rockville, US (HQ)
9700 Great Seneca Highway
Show all (1)
Report incorrect company information

NeuralStem Financials and Metrics

NeuralStem Financials

NeuralStem's revenue was reported to be $16.25 k in FY, 2016
USD

Revenue (FY, 2016)

16.2 k

Net income (FY, 2016)

(21.1 m)

EBIT (FY, 2016)

(20.6 m)

Market capitalization (23-Apr-2018)

21.4 m

Cash (31-Dec-2016)

15.2 m
NeuralStem's current market capitalization is $21.4 m.
Annual
USDFY, 2016

Revenue

16.2 k

General and administrative expense

7.5 m

Operating expense total

7.5 m

EBIT

(20.6 m)
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016

Revenue

5 k5 k2.9 k2.5 k2.5 k2.5 k

General and administrative expense

1.5 m2 m1.4 m1.7 m1.8 m3.2 m

R&D expense

1.9 m2.1 m3.2 m3.3 m3.4 m3.1 m

Operating expense total

3.4 m4 m4.6 m5 m5.2 m6.2 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

16.8 m12.5 m4.7 m15.2 m

Current Assets

17.6 m28.2 m13.5 m20.9 m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016

Cash

15.2 m11.9 m13.6 m8.6 m13.1 m7.6 m

Current Assets

30.8 m27.7 m29.2 m24.7 m19.6 m8.7 m

PP&E

310.1 k301.3 k282.1 k343 k335.9 k337 k

Total Assets

32.6 m29.4 m30.8 m26.4 m21.1 m10.2 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(19.8 m)(22.6 m)(20.9 m)(21.1 m)

Depreciation and Amortization

244.7 k348.6 k345.5 k337.5 k

Accounts Payable

(116.8 k)1.4 m(1 m)879.1 k
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016

Net Income

(6.8 m)(4.5 m)(5.1 m)(5.4 m)(5.6 m)(6.6 m)

Depreciation and Amortization

86.7 k83 k

Accounts Payable

2 m2.4 m2.1 m2.1 m2 m2.6 m
USDY, 2016

Financial Leverage

2 x
Show all financial metrics
Report incorrect company information